This has meant working with global and country partners to generate and analyze data and information and define processes to inform decision-making on malaria vaccines.

Specific areas of this work have included: 

• Data for decision-making: Collaborating with in-country technical bodies and other stakeholders to facilitate the compilation of evidence—including clinical trial data, public health impact estimates, economic analyses, and sociocultural data—for malaria vaccine decisions.
• Policy and regulatory pathways: Mapping the policy pathway of a product—the most efficient movement of the product from development to national decision-making and use. 
• Financing: Encouraging and monitoring the progress and development of financing mechanisms through which the donor community can support malaria vaccines.